Patient id: (b)(6).It was reported that on (b)(6) 2023, one 5.0x40 mm absolute pro stent was implanted in the left distal superficial femoral artery (sfa).On (b)(6) 2023, in-stent restenosis occurred in the stented segment of the distal sfa.The patient was re-admitted to the hospital and the restenosis was successfully treated with angioplasty using a drug coated balloon.No additional information was provided.
|
The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effect of restenosis of stented segment is listed in the absolute pro.035 peripheral self-expanding stent system instructions for use as an adverse event that may be associated with the use of a stent in peripheral arteries and / or biliary tree.A conclusive cause for the reported patient effect, and the relationship to the product, if any, cannot be determined.However, the treatment appears to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|